Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it
Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it
Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Page<br />
Acronym/T<strong>it</strong>le<br />
Contents<br />
85 HIT-4 – Hirudin for the Improvement of Thrombolysis-4<br />
87 TIM – Triflusal in Myocardial Infarction<br />
89 Eptifibatide vs Placebo in Patients Receiving Thrombolytic Therapy<br />
91 JAMIS – Japanese Antiplatelet Myocardial Infarction Study<br />
93 STAMI – Study of Ticlopidine vs Aspirin in Myocardial Infarction<br />
95 ADMIRAL – Abciximab Before Direct Angioplasty and Stenting in<br />
Myocardial Infarction Regarding Acute and Long-Term Follow-Up<br />
98 INTRO AMI – Integrilin and Low-Dose Thrombolysis in Acute<br />
Myocardial Infarction Study<br />
100 CHAMP – Combination Hemotherapy and Mortal<strong>it</strong>y Prevention<br />
102 HART II – Second Trial of Heparin and Aspirin Reperfusion Therapy<br />
104 ENTIRE-TIMI-23 – Enoxaparin and TNK-tPA W<strong>it</strong>h or W<strong>it</strong>hout GP<br />
IIIb/IIIa Inhib<strong>it</strong>or as Reperfusion Strategy in ST Evaluation MI—<br />
Thrombolysis in Myocardial Infarction-23<br />
106 HERO-2 – Hirulog and Early Reperfusion or Occlusion-2 Trial<br />
108 PENTALYSE – Pentasaccharide, as an Adjunct to Fibrinolysis in ST<br />
Elevation Acute Myocardial Infarction<br />
111 CADILLAC – Controlled Abciximab and Device Investigation to Lower<br />
Late Angioplasty Complications<br />
115 PRIME – Promotion of Reperfusion in Myocardial Infarction Evolution<br />
118 VITAL – Vasoflux International Trial for Acute Myocardial Infarction<br />
Lysis<br />
120 Enoxaparin vs Unfractionated Heparin After Thrombolytic Therapy for<br />
Acute Myocardial Infarction<br />
122 ASPECT-2 – Ant<strong>it</strong>hrombotics in the Secondary Prevention of Events in<br />
Coronary Thrombosis-2<br />
124 AMI-SK – Acute Myocardial Infarction Streptokinase<br />
127 ASSENT Plus – Assessment of the Safety and Efficacy of a New<br />
Thrombolytic Plus<br />
129 TIGER-PA – Tirofiban Given in the Emergency Room Before Primary<br />
Angioplasty Pilot Trial<br />
131 Intracoronary vs Intravenous Abciximab in Acute Coronary Syndromes<br />
133 APRICOT-2 – Ant<strong>it</strong>hrombotics in the Prevention of Reocclusion in<br />
Coronary Thrombolysis Trial-2<br />
136 Warfarin, Aspirin, or Both After Myocardial Infarction<br />
Contents<br />
ix
Change language